|
HOME |
|
||||||||||||||||||||
Alphabetical Drug Summaries | ||||||||||||||||||||
Dr. Bob Stein | ||||||||||||||||||||
1) FENTANYL
a) Classification
i) A pure mu agonist b) General Information i) Duration of effect is 30 to 45 minutes c) Advantages/Recommended use
i) Short-term analgesia (1) Excellent as an intra-operative “top up” analgesic ii) Induction agent when combined with a benzodiazepine iii) CRI analgesic use d) Cautionary Information
i) May see panting and muscle rigidity e) Dosage Information
i) Induction (1) See Diazepam & an Opioid section under Induction protocols for details ii) Analgesia (1) Bolus – 0.002 mg/kg (0.001 mg/lb) (2) CRI – 0.001 to 0.004 mg/kg/hr (0.005 to 0.002 mg/lb/hr) (3) Duragesic patch – based upon weight
(a) Small
dogs and cats, use the 25 mcg/hr patch but only expose ½ of the patch
(b) For
even smaller cats consider exposing ¼ of the patch
(c) Never
cut the patch
(d) Clip
hair as closely as possible at planned patch site without irritating the
skin. Gently wipe area once or twice with slightly dampened gauze to
remove loose hair. Let area dry. Warm patch to body temperature. Remove
backing and apply patch to skin. Hold firmly against skin with hand for 2
full minutes. White tape and Kling gauze are used to cover and support the
patch when possible.
(e) For dogs greater than 30 kg, two 50 mcg patches will likely provide better drug delivery than one 100 mcg patch. f) Cost
i) Low per IV use ii) High per patch
2) FIROCOXIB (PREVICOX)
3) FLUMAZENIL (ROMAZICON(R)) a) Classification
i) Benzodiazepine antagonist b) General Information
i) Reversal agent for diazepam and midazolam c) Advantages/Recommended use
i) To reverse any undesirable effects resulting from diazepam or midazolam use d) Cautionary Information
i) None e) Dosage Information
i) Dogs – 0.02 to 0.1 mg/kg (0.01 to 0.05 mg/lb) IV ii) Cats – 0.02 to 0.1 mg/kg (0.01 to 0.05 mg/lb) IV f) Cost
i) Very high |
||||||||||||||||||||
Return to top of page | ||||||||||||||||||||
Questions or problems regarding this web site should be directed to DRSTEIN@VASG.ORG . Copyright © 2003 ASAH. All rights reserved. Last modified: February 22, 2011 . |
||||||||||||||||||||